Triglyceride-rich lipoproteins and remnant cholesterol are key drivers of cholesterol accumulation in myocardial infarction and incident cardiovascular disease [47,48], and genetic and therapeutic reduction of apoC-III significantly reduces the incidence of cardiovascular disease [49,50]. The gene discussed is APOC3; the disease is myocardial infarction.